Answers are grounded in this paper and cite their sources.
Review highlights the lack of approved pharmacotherapy for obstructive sleep apnea management, suggesting a need for further research.
Obstructive sleep Apnea (OSA) is chronic condition that is characterized by repeated episodes of complete (Apnea) or partial (hypopnea) obstruction of the upper airways during sleep. Over the past few decades, management of OSA did not change significantly. Treatment offered for patients with OSA includes behavioral modification such as exercise and wright loss, Positive Airway Pressure (PAP) therapy, mandibular advancement appliances and surgical intervention in a subset of patients. Unfortunately, up to date there is no approved pharmacotherpy for OSA managmengt despite multiple attempts to thoroghly investigate a potential aletrnative and easy accessable pharmacological management for patients with OSA. In this review, we will shed somelight on the current knowledge of pharmacological therapy for patients with OSA.
No takes yet. Share an insight, caveat, or question.
Faris Alhejaili (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: